Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04623216
Title Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries ITA | FRA | ESP | DEU

Facility Status City State Zip Country Details
Novartis Investigative Site COMPLETED Marseille 13273 France Details
Novartis Investigative Site WITHDRAWN Paris 10 75475 France Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Freiburg 79106 Germany Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Hamburg 20246 Germany Details
Novartis Investigative Site WITHDRAWN Leipzig 04103 Germany Details
Novartis Investigative Site COMPLETED Muenster 48149 Germany Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Bergamo BG 24128 Italy Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Bologna BO 40138 Italy Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Brescia BS 25123 Italy Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Roma RM 00165 Italy Details
Novartis Investigative Site WITHDRAWN Salamanca Castilla Y Leon 37007 Spain Details
Novartis Investigative Site COMPLETED Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site RECRUITING Las Palmas de Gran Canaria 35010 Spain Details
Novartis Investigative Site WITHDRAWN Madrid 28009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field